KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
9.00
+0.04 (0.45%)
Nov 21, 2024, 1:38 PM EST - Market open

KalVista Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
150
Market Cap
388.94M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022---
Apr 30, 2021---
Apr 30, 202012.69M-3.44M-21.31%
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 694.97M
Revance Therapeutics 256.95M
Sonida Senior Living 253.20M
Canopy Growth 207.63M
Rigel Pharmaceuticals 157.37M
Aquestive Therapeutics 58.90M
Sangamo Therapeutics 52.29M
Prime Medicine 800.00K
Revenue Rankings